Constantine Tam

Prof Constantine Tam, academic hematologist from Monash University, explains recent CLL datasets from ASH and what they mean for patient care. He discusses moving from continuous BTKi to time-limited oral doublets, challenges and practical tips for venetoclax delivery and ramp-up, the promise of somerotoclax for deeper MRD clearance, and strategies around BTKi selection, relapse management, CAR T timing, and future fixed-duration approaches.